News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Company Profile For Alcon


10/19/2005 5:11:01 PM

--(BUSINESS WIRE)--Alcon is the global leader in the research, development, manufacture and marketing of ophthalmic products, including surgical instruments and accessory products, intraocular lenses, prescription drugs and contact lens care solutions.

Founded in Fort Worth, Texas in 1947, Alcon now employs more than 12000 individuals around the world. Total sales for 2003 were $3.4 billion, with activity in more than 175 markets. One of the cornerstones of Alcon's success is the company's commitment to Research and Development. Housed at the company's U.S. general offices in Fort Worth is the 400,000 square-foot William C. Conner Research Center, the largest and most sophisticated eye research center in the world. Other research centers include the Irvine Technology Center, a surgical instrument research facility in Irvine, California, and the Orlando Technology Center, a refractive research facility in Orlando, Florida. Over the next five years, Alcon plans to spend more than $2 billion on eye-related research, more than any other pharmaceutical company.

Company: Alcon, Inc.

Headquarters Address: 56 Bosch P.O. Box 62 Huenenberg CH-6331 Switzerland

Main Telephone: 41+41 785 8888

Website: www.alconinc.com

Ticker: NYSE:ACL

Type of Organization: Public

Industry: Health: Pharmaceutical

Earnings Release Dates: 1st Quarter: April 20, 2004 2nd Quarter: July 28, 2004 3rd Quarter: October 20, 2004 4th Quarter: February 9, 2005

Key Executives: CEO, Chairman and President: Tim Sear CFO: Jacqualyn Fouse SVP: Cary Rayment

Public Relations Contact: Mary Dulle Phone: 817-551-8058 Email: mary.dulle@alconlabs.com

Public Relations Contact: Jerri Robbins Phone: 817-551-8776 Email: jerri.robbins@alconlabs.com

Investor Relations Contact: Investor Relations Phone: 800-400-8599 Email: investor.relations@alconlabs.com

Contacts

Alcon, Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES